home · filing · 0001193125-23-193471
8-K
filed July 25, 2023, 7:59 PM ET
ticker BBWI
CIK 0000701985
leadership
confidence high
sentiment neutral
materiality 0.55
Bath & Body Works appoints Eva Boratto as CFO effective August 1, 2023
Bath & Body Works, Inc.
Eva Boratto named CFO, succeeds Wendy Arlin who steps down July 29, 2023.
Boratto most recently CFO of Opentrons Labworks; earlier EVP & CFO of CVS Health.
Base salary $850,000; target cash incentive 120% of salary; initial equity award $2.75M.
Receives sign-on RSUs valued at $2.0M and cash sign-on bonus of $1.0M.
Boratto has over 30 years of finance experience, including 20 years at Merck.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2023-07-29
Successor Eva C. Boratto
Filed July 25, 2023, 7:59 PM ET
Wendy C. Arlin will cease serving as Chief Financial Officer effective as of July 29, 2023.
Effective 2023-08-01
Successor Wendy C. Arlin
Filed July 25, 2023, 7:59 PM ET
appointed Eva C. Boratto as the Chief Financial Officer of the Company effective as of August 1, 2023.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Wendy C. Arlin departed as Chief Financial Officer at Bath & Body Works, Inc..
Action ceased serving
Role Chief Financial Officer
Exact text from the filing
Wendy C. Arlin will cease serving as Chief Financial Officer effective as of July 29, 2023.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Eva C. Boratto was appointed as Chief Financial Officer at Bath & Body Works, Inc..
Action appointed
Role Chief Financial Officer
Exact text from the filing
appointed Eva C. Boratto as the Chief Financial Officer of the Company effective as of August 1, 2023.
View on SEC.gov
Source: SEC EDGAR
accession 0001193125-23-193471
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.